KORU Medical Systems (NASDAQ:KRMD) reported second-quarter revenue of $12 million, up 18% from a year earlier, as domestic patient starts, market-share gains and international demand supported growth. Revenue growth led by domestic and international core businessChief Financial Officer Tom Adams said domestic core revenue totaled $8 million, an increase of 12% year over year. International timing prompts narrower revenue outlookKORU narrowed its full-year revenue outlook to a range of $47.5 million to $48.5 million. Connected technology acquisition and pipeline updatesDuring the quarter, KORU acquired a connected monitoring technology asset intended to add data and connectivity capabilities to its mechanical infusion systems. About KORU Medical Systems (NASDAQ:KRMD)KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally.